EMAIL THIS PAGE TO A FRIEND

Neurobiology of aging

Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients.


PMID 15465626

Abstract

Experimental and clinical studies give evidence for breakdown of membrane phospholipids during neurodegeneration. In the present study, we measured the levels of glycerophosphocholine (GPCh), phosphocholine (PCh), and choline, that is, water-soluble metabolites of phosphatidylcholine (PtdCho), in human cerebrospinal fluid (CSF). Among 30 cognitively normal patients the average CSF levels of GPCh, phosphocholine and choline were 3.64, 1.28, and 1.93 microM, respectively; metabolite levels did not change with increasing age. When compared with age-matched controls, patients with Alzheimer's disease had elevated levels of all choline metabolites: GPCh was significantly increased by 76% (P<0.01), phosphocholine by 52% (P<0.05), and free choline (Ch) by 39%. Six patients with vascular dementia had lower choline and elevated phosphocholine levels, when compared to controls, but normal levels of GPCh. These data demonstrate that Alzheimer's disease is accompanied by an increased PtdCho hydrolysis in the brain. PtdCho breakdown seems to be mediated by phospholipase A2 and leads to significantly elevated levels of GPCh in CSF.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

67520
1-Methyl-L-histidine, ≥98.0% (TLC)
C7H11N3O2
310360
Aluminum, ACS reagent, 99%, wire, wire diam. ~1.5 mm
Al
IRMM523A
Aluminum, IRMM® certified Reference Material, 0.1 mm foil
Al
IRMM523B
Aluminum, IRMM® certified Reference Material, 1.0 mm foil
Al
IRMM523C
Aluminum, IRMM® certified Reference Material, 1.0 mm wire
Al
265063
Beryllium, chunks, 99.9%
Be
378135
Beryllium, powder, −325 mesh, ≥99%
Be
D0256
Dulcitol, ≥99%
C6H14O6
47910
Fumaric acid, ≥99.0% (T)
C4H4O4
03761
Fumaric acid, tested according to USP/NF
C4H4O4
F0600000
Fumaric acid, European Pharmacopoeia (EP) Reference Standard
C4H4O4
76635
Fumaric acid, certified reference material, TraceCERT®
C4H4O4
G3002
Gly-Pro
C7H12N2O3
A3506
L-(−)-Arabitol, ≥98%
C5H12O5
A1879
L-2-Aminobutyric acid, ≥99% (titration)
C4H9NO2
A2536
L-2-Aminobutyric acid, BioReagent, suitable for cell culture
C4H9NO2
A1269000
L-Arabinitol, European Pharmacopoeia (EP) Reference Standard
C5H12O5
C7505
L-Cystathionine, ≥98% (TLC)
C7H14N2O4S
M-080
Methylmalonic acid solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material
C4H6O4
343250
Silicon, pieces, 99.95% trace metals basis
Si
267414
Silicon, powder, −60 mesh, 99.999% trace metals basis
Si
215619
Silicon, powder, −325 mesh, 99% trace metals basis
Si
647535
Silicon, wafer (single side polished), <100>, N-type, contains no dopant, diam. × thickness 3 in. × 0.5 mm
Si
647780
Silicon, wafer (single side polished), <100>, N-type, contains phosphorus as dopant, diam. × thickness 2 in. × 0.5 mm
Si
647802
Silicon, wafer (single side polished), <100>, N-type, contains phosphorus as dopant, diam. × thickness 3 in. × 0.5 mm
Si
647764
Silicon, wafer (single side polished), <100>, P-type, contains boron as dopant, diam. × thickness 3 in. × 0.5 mm
Si
647101
Silicon, wafer (single side polished), <111>, N-type, contains no dopant, diam. × thickness 2 in. × 0.5 mm
Si
647543
Silicon, wafer (single side polished), <111>, N-type, contains no dopant, diam. × thickness 3 in. × 0.5 mm
Si
647799
Silicon, wafer (single side polished), contains phosphorus as dopant, <111>, N-type, diam. × thickness 2 in. × 0.5 mm
Si
647705
Silicon, wafer, <111>, P-type, contains boron as dopant, diam. × thickness 2 in. × 0.3 mm
Si